C21 Investments’ CEO to address Annual Cannabis Conference in New York

View Full News Release

C21 Investments Inc. (CSE: CXXI and OTC: CXXIF) today announced that its President and Chief Executive Officer, Robert Cheney, will join other cannabis industry experts at the Canaccord Genuity’s 3rd Annual Cannabis Conference and present.  C21 Investments Inc. is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States.

Mr. Cheney is scheduled to present at 3:00pm EST time on Tuesday, May 14, 2019, and his presentation will be available via webcast at:  http://wsw.com/webcast/canaccord34/ctoi/.  Mr. Cheney is available for meetings and media interviews during the conference.

C21 Investments recently reported unaudited revenue of US$7.7 million for the 1st quarter ended April 30, 2019.  This amount reflects revenue from the Company’s operations in Nevada and Oregon.  Unaudited gross margin (before fair value adjustments) is estimated to be 54%.  During the quarter, C21’s retail dispensaries completed 140,000 customer transactions.  These figures do not include revenue from Swell Companies.

After the completion of the acquisition of Swell Companies, the C21 Investments group of companies will have 140,000 sq. ft. of cultivation space (both indoor and outdoor) with another 165,000 sq. ft. available for cultivation, extraction or wholesale distribution; 11,000 sq. ft. of wholesale distribution; 13,000 sq. ft. of extraction; and 17,000 sq. ft of retail distribution.


The CSE has not accepted responsibility for the adequacy or accuracy of this release.

Certain statements contained in this news release may constitute forward-looking statements within the meaning of applicable securities legislation. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Forward looking statements in this news release include the unaudited revenue at March 31, 2019, estimated gross margin at March 31, 2019, expected closing of acquisition of Swell companies in April; anticipated timelines for issuance of future revenue reports and the impact of the acquisitions on the Company’s financial information.

The forward-looking statements contained in this news release are based on certain key expectations and assumptions made by C2, including the acquisition of the Swell companies in April and the reliability of the revenue and gross margin at March 31. Although C21 believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because C21 can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the failure to obtain necessary regulatory approvals or satisfy the conditions to closing if the acquisition of the Swell companies in April, C21’s inability to finance and complete the acquisition or, to integrate and expand the acquired businesses as planned, competitive factors in the industries in which C21 operates, prevailing economic and regulatory conditions, and other factors, many of which are beyond the control of C21.

 The forward-looking statements contained in this news release represent C21’s expectations as of the date hereof, and are subject to change after such date. C21 disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required under applicable securities regulations.